Intratumoral Immunotherapy With XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus-Derived Vectors Fosters Dendritic Cell-Mediated T Cell Cross-Priming
Cancer Research - United States
doi 10.1158/0008-5472.can-18-0933
Full Text
Open PDFAbstract
Available in full text
Date
October 8, 2018
Authors
Publisher
American Association for Cancer Research (AACR)